Want to join the conversation?
$ABT 2Q15 Call: Diagnostics achieved sales growth of 9%, driven by continued above-market performance in Core Lab and point-of-care diagnostics. In Nutrition, sales increased 4%, slightly below expectations. In Medical Devices, diabetics care delivered 5% growth. In Established Pharmaceuticals, sales increased double digits.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.